Showing posts with label Tox. Show all posts
Showing posts with label Tox. Show all posts

Thursday, August 26, 2010

Digoxin Toxicity


Indications for DigiFab (FDA label = pdf link)
1. Acute ingestion of 10mg or more in previously healthy adults or 4mg in a previously healthy children. Or a level of 10ng/mL or more
2. Chronic ingestion of 6 ng/mL (4 ng/mL in kids)
3. Life-threatening toxicity.
  • VT or VF
  • Progressive Bradycardia
  • 2nd or 3rd AVB not responsive to atropine
  • K > 5.5 (6 in kids) with rapidly progressive s/s of Dig Tox. [in Circulation 2010, can give empiric DigiFab in acute Digoxin poisoning if K is >5]


Strategies for administration of Antidigoxin Fab (DigiFab)
1 vial of DigiFab (40mg) = neutralizes 0.5mg of Digoxin
ng/mL is the same as mcg/L
Life-threatening cardiac glycoside toxicity, DigiFab should be given (Class I, LOE B)
  • Known dose of digoxin taken, 2 vials of DigiFab = 1mg of Dig
  • If chronic dig tox or when dose taken of dig unknown: dig level x weight in kg = number of vials to be given
  • Life-threatening highly suspected Dig Tox where level could not be immediately obtained, administer empirically 10 to 20 vials
(Circulation, 2010;122:S829-S861) (pdf link here: Cardiac Arrest in Special Situation)

Adverse Effects of DigiFab:
1. Hypokalemia (due to reactivation of Na-K ATPase)
2. Worsening of CCF (due to withdrawal of inotropic effect of digoxin)
3. Rapid Ventricular response in AF (due to withdrawal of digoxin effect on AV node)

Notes:
  • Hyperkalemia is both a marker of severity of Dig Tox and associated with poor prognosis
  • After DigiFab administration, Dig level may misleadingly increase as DigiFab binds with Dig (Dig level measures both bound and free Dig) until DigiFab is eliminated from the body (may be several days or weeks if renal impairment). Free Dig is the one toxic
  • Dig shifts K from inside to outside cell = hyperkalemia, this may lead to increase urinary excretion of K so that patient has hyperkalemia but a whole body deficit of K. When DigiFab reverses dig tox, K shifts back into cell = rapid decline in K concentration.
  • Hypokalemia may occur rapidly and so K must be monitored especially the next few hours and corrected accordingly

CCB Toxicity


1. Bradycardia + Hypotension
2. Hyperglycemia -- treat with insulin

Beta Blocker Toxicity

1. Bradycardia + Hypotension
2. Hypoglycemia

Saturday, June 26, 2010

Drugs That Prolong QT

Drugs which people with Long QT Syndrome should avoid

Below is a list of the drugs that people with Long QT Syndrome should avoid. A similar list can also be found by clicking here.

Neither of these lists should be considered exhaustive, and you should always check with your GP and pharmacist if your doctor prescribes any new drugs for you, as these lists may not be complete.

* = Drugs which are unlicensed, withdrawn or suspended in the UK market

A - Z List


Adrenaline (Epinephrine)
Stimulant

Ajmaline*


Antiarrhythmic (Class 1)

Alfuzosin
Alpha1-blocker

Almokalant*
Antiarrhythmic (Class 3)

Amantidine
Antimalarial

Amiodarone
Antiarrhythmic (Class 3)

Amitriptyline


Psychiatric drug - Tricyclic antidepressant

Amoxapine*
Psychiatric drug - Tricyclic antidepressant

Amphetamine
Stimulant

Arsenic trioxide
Anti-cancer

Astemizole*


Antihistamine

Atomoxetine
Psychiatric drug - Other

Azelastine
Antihistamine

Azimilide*


Antiarrhythmic (Class 3)

Azithromycin
Antibiotic - Macrolide

Bepridil*
Anti-anginal / vasodilator

Bretylium
Antiarrhythmic (Class 3)

Chloral hydrate
Sedative

Chloroquine
Antimalarial

Chlorpromazine
Psychiatric drug - Phenothiazine

Cibenzoline*
Antiarrhythmic (Class 1)

Ciprofloxacin
Antibiotic - Quinolone

Cisapride*
Serotonin agonist / antagonist

Citalopram
Psychiatric drug - Other

Clarithromycin
Antibiotic - Macrolide

Clobutinol*
Other

Clomipramine

Psychiatric drug - Tricyclic antidepressant


Clozapine
Anti-psychotic

Cocaine
Stimulant

Cold remedies
May contain stimulant drugs - always to check the label

Cotrimoxazole
Antibiotic - Antifungal

d-sotalol*
Antiarrhythmic (Class 3)

Desipramine*
Psychiatric drug - Tricyclic antidepressant

Dexmethylphenidate
Stimulant

Dihydroquinidine*
Antiarrhythmic (Class 1)

Diphenhydramine
Antihistamine

Disopyramide
Antiarrhythmic (Class 1)

Dobutamine
Stimulant

Dofetilide*
Antiarrhythmic (Class 3)

Dolasetron
Serotonin agonist / antagonist

Domperidone
Other

Dopamine
Stimulant

Doxepin
Psychiatric drug - Tricyclic antidepressant

Dronedarone*
Antiarrhythmic (Class 3)

Droperidol*
Psychiatric drug - Other

Ebastine*
Antihistamine

Encainide*
Antiarrhythmic (Class 1)

Ephedrine
Stimulant

Ersentilide*
Antiarrhythmic (Class 3)

Erythromycin
Antibiotic - Macrolide

Felbamate*
Anticonvulsant

Fenfluramine
Stimulant

Flecainide
Antiarrhythmic (Class 1)

Fluconazole
Antibiotic - Antifungal

Fluoxetine
Psychiatric drug - Other

Fluphenazine
Psychiatric drug - Phenothiazine

Foscarnet (HIV)
Antibiotics - Antiviral

Fosphenytoin (prodrug of Phenytoin)
Anticonvulsant

Galantamine
Inhibitor (dementia, Alzheimer's)

Gatifloxacin*


Antibiotic - Quinolone


Geldanamycin*


Anti-cancer


Gemifloxacin*
Antibiotic - Quinolone

Granisetron
Serotonin agonist / antagonist

Grepafloxacin*
Antibiotic - Quinolone

Halofantrine*
Antimalarial

Haloperidol
Psychiatric drug - Other

Hydroxyzine
Antihistamine

Ibutilide*
Antiarrhythmic (Class 3)

Imipramine
Psychiatric drug - Tricyclic antidepressant

Indapamide
Anti-hypertensive

Isoprenaline (Isoproterenol)
Stimulant

Isradipine
Anti-hypertensive

Itraconazole
Antibiotic - Antifungal

Ketanserin*
Serotonin agonist / antagonist

Ketoconazole
Antibiotic - Antifungal

Levalbuterol
Stimulant

Levofloxacin
Antibiotic - Quinolone

Levomethadyl*
Psychiatric drug - Other

Lidoflazine*
Anti-anginal / vasodilator

Lithium
Anti-mania

Maprotiline
Psychiatric drug - Other

Mesoridazine
Psychiatric drug - Other

Metaproterenol
Stimulant

Methadone
Psychiatric drug - Other

Methylphenidate
Stimulant

Mexiletine
Antiarrhythmic (Class 1)

Midodrine
Stimulant

Moexipril / Hydrochlorthiazide
Anti-hypertensive

Moxifloxacin
Antibiotic - Quinolone

Naratriptan
Anti-migraine

Nicardipine
Anti-hypertensive

Nifekalant*
Antiarrhythmic (Class 3)

Norepinephrine (Noradrenaline)
Stimulant

Nortriptyline
Psychiatric drug - Tricyclic antidepressant

Octreotide


Other

Ofloxacin
Antibiotic - Quinolone

Ondansetron
Serotonin agonist / antagonist

Organophosphates*
Other

Paroxetine
Anti-depressant

Pentamidine
Antibiotic - Other

Perflutren lipid microspheres
Other

Pericycline
Psychiatric drug - Other

Phentermine
Stimulant

Phenylephrine
Stimulant

Phenylpropanolamine
Stimulant

Pimozide
Psychiatric drug - Other

Pirmenol*
Antiarrhythmic (Class 1)

Prenylamine*
Anti-anginal / vasodilator

Probucol
Other

Procainamide
Antiarrhythmic (Class 1)

Prochlorperazine
Psychiatric drug - Phenothiazine

Propafenone


Antiarrhythmic (Class 1)

Protriptyline*
Psychiatric drug - Tricyclic antidepressant

Pseudoephidrine
Stimulant

Quetiapine
Psychiatric drug - Other

Quinidine*
Antiarrhythmic (Class 1)

Quinine
Antimalarial

Ranolazine
Anti-anginal / vasodilator

Risperidone
Psychiatric drug - Other

Ritodrine
Stimulant

Roxithromycin*
Antibiotic - Macrolide

Salbutamol (Albuterol)
Stimulant

Salmeterol
Stimulant

Sematilide*
Antiarrhythmic (Class 3)

Sertindole
Psychiatric drug - Other

Sertraline
Anti-depressant

Sibutramine
Stimulant

Solifenacin
Other

Sotalol
Antiarrhythmic (Class 3)

Sparfloxacin*
Antibiotic - Quinolone

Spiramycin
Antibiotic - Macrolide

Sumatriptan
Anti-migraine

Sunitib
Anti-cancer

Tacrolimus
Anti-cancer

Tamoxifen


Anti-cancer

Telithromycin
Antibiotic - Macrolide

Terbutaline
Stimulant

Terfenadine*
Antihistamine

Terikalant*
Antiarrhythmic (Class 3)

Terodiline*
Anti-anginal / vasodilator

Thioridazine*
Psychiatric drug - Phenothiazine

Tizanidine


Other

Tolterodine
Bladder antispasmodic

Trazodone
Psychiatric drug - Other

Trifluoperazine
Psychiatric drug - Phenothiazine

Trimethoprim sulfa (bactrim)
Antibiotic - Other

Trimipramine


Psychiatric drug - Tricyclic antidepressant


Vardenafil
Anti-anginal / vasodilator

Vasopressin
Other

Venlafaxine
Psychiatric drug - Other

Voriconazole
Antibiotic - Antifungal

Zimeldine*
Psychiatric drug - Other

Ziprasidone
Psychiatric drug - Other

Zolmitriptan
Anti-migraine

Listed by type

Antiarrhythmics
Class 1: ajmaline*, cibenzoline*, dihydroquinidine*, disopyramide, encainide*, flecainide, mexiletine, pirmenol*, procainamide, propafenone quinidine*
Class 3: almokalant*, amiodarone, azimilide*, bretylium, dofetilide*, dronedarone*, d-sotalol*, ersentilide*, ibutilide*, nifekalant*, sematilide*, sotalol, terikalant*

Anti-anginals/vasodilators
bepridil*, lidoflazine*, prenylamine*, ranolazine, terodiline*, vardenafil

Anti-hypertensives
indapamide, isradipine, moexipril/hydrochlorthiazide, nicardipine

Antihistamines
astemizole*, azelastine, diphenhydramine, ebastine*, hydroxyzine, terfenadine*

Serotonin agonists and antagonists
cisapride*, dolasetron, granisetron, ketanserin*, ondansetron

Antimicrobials
Macrolide antibiotics: azithromycin, clarithromycin, erythromycin, roxithromycin*, spiramycin, telithromycin
Quinolone antibiotics: ciprofloxacin, gatifloxacin*, gemifloxacin*, grepafloxacin*, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin*
Antifungals: cotrimoxazole, fluconazole (caution with itraconazole), ketoconazole, voriconazole
Others: pentamidine, trimethoprim sulfa (bactrim)
Antiviral: foscarnet (HIV)

Antimalarials
amantidine, chloroquine, halofantrine*, quinine

Psychiatric drugs
Tricyclic antidepressants: amitriptyline, amoxapine*, clomipramine, desipramine*, doxepin, imipramine, nortriptyline, protriptyline*, trimipramine
Phenothiazines: chlorpromazine, fluphenazine, prochlorperazine, thioridazine*, trifluoperazine
Others: atomoxetine, citalopram, clozapine, droperidol*, fluoxetine, haloperidol, levomethadyl*, lithium, maprotiline, mesoridazine, methadone, paroxetine, pericycline, pimozide, quetiapine, risperidone, sertindole, sertraline, trazodone, venlafaxine, zimeldine*, ziprasidone

Anticonvulsant
felbamate*, fosphenytoin (prodrug of phenytoin)

Anti-migraine
naratriptan, sumatriptan, zolmitriptan

Anti-cancer
arsenic trioxide, geldanamycin*, sunitib, tacrolimus, tamoxifen

Others
alfuzosin, chloral hydrate, clobutinol*, domperidone, galantamine, octreotide, organophosphates*, perflutren lipid microspheres, probucol, solifenacin, tizanidine, tolterodine, vasopressin

Stimulant drugs
Some cold remedies contain these drugs so it is important always to check the label.
adrenaline (epinephrine), amphetamine, cocaine, dexmethylphenidate, dobutamine, dopamine, ephedrine, fenfluramine, isoprenaline (isoproterenol), levalbuterol, metaproterenol, methylphenidate, midodrine, norepinephrine (noradrenaline), phentermine, phenylephrine, phenylpropanolamine, pseudoephidrine, ritodrine, salbutamol (albuterol), salmeterol, sibutramine, terbutaline


Source: Sads.org.uk

Monday, June 21, 2010

Dabigatran Overdose

http://www.thepoisonreview.com/2011/06/18/dabigatran-etexilate-a-new-challenge-for-emergency-physicians-and-toxicologists/

  • PCC: Protein Complex Concentrate - effective in reducing anticoagulation effect
  • FEIBA: Factor Eight Inhibitor Bypass Activity - very potent PCC combination that has activated clotting factors, so this may be one thing to consider, but clearly there is a paucity of clinical data about how to best do this

Sunday, June 6, 2010

Toxicology Approach

Toxicology
Risk assessment-based Approach: (Murray)
Resus-RSI-DEAD

Resuscitation (ABCDE)
  • ABC
  • Detect and correct (Hypogly, Sz, Hyper/hypothermia)
  • Emergency Antidote Administration

Risk Assessment (ADTCP)
  • Agent
  • Dose
  • Time since ingestion
  • Clinical features and course
  • Patient factors (weight and co-morbidities)

Supportive care and monitoring
Investigations
  • Screening: 12 lead ECG, paracetamol
  • Specific
Decontamination
Enhanced Elimination
Antidotes
Disposition
-----
RESUSCITATION
- acute poisoning associated with good neuro outcome (vs cardiac arrest in older patients) even after prolonged resus (hours)
- continue resus while obtaining expert advice
- cardiopulmonary bypass has been successful in some cases
- resus + supportive care are the priority NOT skin/GI decontamination

ABC
- with focus on AMS, loss of airway reflex, hypotension
- GCS <12 associated with increased risk of aspiration

AIRWAY
1. Airway Compromise
Mech: Corrosive injury to oropharynx
Agents: Alkalis, Acids, Glyphosate, Paraquat
Comments:
- Stridor, dysphagia and dysphonia indicate airway injury and potential for imminent airway compromise
- Early ET intubation or surgical airway often required

BREATHING
1. Acidosis/Acidemia
Mech: various
Agents: Ethylene glycol, Methanol, Salicylates
Comments:
- Until late in the clinical course there is usually prominent respiratory compensation
- Intubation and ventilation at standard settings may worsen acidemia and precipitate rapid clinical deterioration, if not death
- Avoid normo- or hypoventilation
- Maintain hyperventilation and consider bolus IV NaHCO3 1-2 mmol/kg to prevent worsening of acidemia

2. Hypoventilation
Mech: Opioid mu receptor stimulation
Agents: Opioids
Comments: Prompt administration of naloxone may obviate need for intubation and ventilation

3. Respiratory Failure
Mech: Cholinergic crisis
Agents: Carbamates, Nerve agents, OrganoPO4
Comments: Rapid administration of atropine by serial doubling of atropine dose to achieve dry respiratory secretions may restore adequate oxygenation

4. Acidosis, Hypoxaemia, Multi Organ Failure (MOF)
Mech: Oxygen-free radical mediated cellular injury, particularly type II pneumocytes
Agents: Paraquat
Comments:
- Avoid supplemental oxygen
- If hypoxia occurs, titrate supplemental oxygen to maintain oxygen saturation of ~ 90% or PaO2 60mmHg

CIRCULATION
1. Ventricular fibrillation
Mech: Hypocalcaemia
Agents: Hydroflouric acid ingestion or massive cutaneous burn
Comments:
- Defibrillation alone unlikely to be efficacious
- Bolus IV calcium (eg 60-90 mL of 10% calcium gluconate) repeated as required every 2 minutes until defibrillation restores perfusing rhythm

2. Ventricular tachycardia
Mech: Fast Na+ channel blockade
Agents: Chloroquine, Cocaine, Flecainide, Local anaesthetic agents, Procainamide, Propranolol, Quinine, TCA
Comments:
- Cardioversion or defibrillation unlikely to be efficacious
- Urgently intubate and hyperventilate
- Bolus IV NaHCO3 1-2 mmol/kg repeat every 1-2 minutes until restoration of perfusing rhythm
- Do not await serum pH determination prior to intubation and NaHCO3 boluses
- Lignocaine is third-line therapy when pH is established at >7.5
- Amiodarone and Vaughn Williams type 1a antiarrhythmics (eg procainamide) are contraindicated

3. Ventricular ectopy/tachycardia
Mech: Halogen-induced myocardial sensitisation to catecholamines
Agents: Chloral hydrate, Organochlorines
Comments:
- Cardioversion or defibrillation unlikely to be efficacious
- Administer IV beta-blockers, titrate to ectopy response

4. SVT
Mech: Adenosine antagonism
Agents: Theophylline
Comments: Urgent haemodialysis

5. Tachycardia
Mech: Central and peripheral sympathomimetic response
Agents: Amphetamines, Cocaine
Comments:
- Beta-blockers contraindicated
- Administer IV benzodiazepines, titrated to gentle sedation and HR control

6. Asystole, Bradycardia, Tachycardia
Mech: Na+/K+ ATPase pump inhibition
Agents: Digoxin
Comments:
- Usual resuscitative interventions futile
- Digoxin-specific antibodies

7. Bradycardia, Hypotension, Conduction defects
Mech: Calcium Channel blockade
Agents: CCB
Comments:
- Atropine and pacing unlikely to be efficacious
- Bolus IV Calcium (eg 60 mL of 10% calcium gluconate) may provide temporary haemodynamic stability by increasing HR and BP, while other treatments are organised
- High-dose insulin-dextrose therapy

8. Refractory hypotension
Mech: Various
Agents: Beta-blockers, CCB, local anaesthetics
Comments: High-dose insulin-dextrose therapy

9. Hypertension
Mech: Central and peripheral sympathomimetic response
Agents: Amphetamines, Cocaine
Comments:
- Beta-blockers contraindicated
- Administer IV benzodiazepines, titrated to gentle sedation and HR control
- If further treatment necessary, use titratable agents like:
GTN, Nitroprusside, Phentolamine

10. ACS
Mech: Central and peripheral sympathomimetic response
Agents: Amphetamines, Cocaine
Comments:
- Beta-blockers contraindicated
- Benzo
- GTN
- Antiplatelet adn anticoagulation therapy if no neurological deficits (otherwise cranial CT first)
- Reperfusion therapy along conventional lines

OTHER
1. Hyperkalaemia
Mech: Na+/K+ ATPase pump inhibition
Agents: Digoxin
Comments:
- Calcium salts contraindicated
- Digoxin-specific antibodies

2. Hypoglycaemia
Mech: Hyperinsulinaemia
Agents: Sulfonylureas
Comments:
- difficult to maintain euglycaemia with dextrose alone
- Ocreotide administration obviates need for dextrose supplementation

3. Refractory Seizures
Mech: Inhibition of GABA production
Agents: Isoniazid
Comments: IV pyridoxine: 1 gram per gram of isoniazid ingested, up to 5 grams

4. Seizures
Mech: Adenosine antagonism
Agents: Theophylline
Comments: Urgent haemodialysis

Detect and Correct Seizures
- Toxic seizures are generalised
- Usually controlled by benzos (diazepam, midazolam, lorazepam or clonazepam)
- most commonly caused in Australasia by:
1. Venlafaxine
2. Bupropion
3. Tramadol
4. Amphetamines
- focal/partial seizure is either a complication of poisoning or needs further consideration of non-tox cause
- 2nd line: Barbiturate
- 3rd line: Pyridoxine due to INZ poisoning
- Phenytoin is contraindicated for toxic seizures

Detect and Correct Hypoglycaemia
- if <4 mmol/L = give 50-50 (50 mls of 50% Dextrose), 5mL/kg of 10% Dextrose in kids
- Associated with:
1. Insulin and Sulfonylurea OHA
2. Beta-blockers
3. Quinine
4. Chlorquine
5. Salicylates
6. Valproic acid

Detect and Correct Hyper-/Hypothermia
- Hyperthermia is associated with life-threatening poisonings and poor outcome
- >38.5'C: needs continuous core-temperature monitoring
- >39.5'C: emergency to intervene and prevent MOF and neuro injury; NM paralysis with intubation and ventilation helps to stop muscle-generated heat production and rapid reduction of temperature
- Profound hypothermia (<29'C core): mimics or cause cardiac arrest: coma, fixed pupils, brady (usually Af), hypotension; Aggressive exogenous rewarming while CPR. Most effective is CP bypass. Alternative is pleural lavage through intercostal catheter with large volumes of fluid warmed to 40-45'C.

Emergency Antidote Administration
- sometimes indicated during resus
- examples: DANS
1. Sodium Bicarb for TCA
2. Naloxone for Opioids
3. Atropine for OrganoPO4
4. Digoxin-specifc antibodies for Digoxin with cardiovascular compromise

RSI

Risk Assessment (ADTCP)
1. Agent
2. Dose and type (eg ?sustained release)
3. Time since ingestion:
eg. TCA life threats occur within 6 hours (usu. within 2 hours), therefore low-risk patients can be identified 6 hours post ingestion)
4. Clinical features and course/progress
5. Patient factors (weight and co-morbidities)

Backup history:
1. Ask ambulance officers or family to search for agents
2. Counting missing tablets
3. Checking medical records for previous prescriptions
4. Question relatives about agents available to patient

Wednesday, December 3, 2008

Paracetamol Overdose



  • Overdose is 150 mg/kg (7.5, 9, 10.5 gram for 50, 60, 70 kg patient respectively)
    Phase I:
    • 12-24 hours
    • GI symptoms, N/V, anorexia, diaphoresis, pallor
    • coma is rare
    • most patients recover and does not go beyond Phase I
    Phase II
    • if toxicity continues, this is the latent phase of up to 48 hours
    • Symptoms abate and patient feels better BUT
      rising and striking levels of AST/ALT, PT/INR, bilirubin, lactate, phosphate
    • RUQ pain due to liver enlargement and tenderness
    • most patients does not go beyond this phase
    Phase III
    • rare, serious hepatic necrosis; 3-5 days after ingestion
    • + jaundice, confusion, stupor, coagulation defect, hypoglycemia, encephalopathy, renal failure, cardiomyopathy
    • death if it occurs is due to fulminant hepatic failure
    • mortality rate for toxic level without treatment is 3-4%

  • Paracetamol metabolism: in the liver
    - 3 pathways for metabolism; (1) and (2) are major
    (1) Glucoronidation: glucoronide conjugate (not toxic) -> cleared by the kidneys
    (2) Sulfation: sulfate conjugate (not toxic) -> cleared by the kidneys
    (3) Cytochrome p450: NAPQI (N-Acetyl P-benzoQuinone Imine) (toxic) -> conjugates with sulfhydryl group of glutathione -> excreted to kidneys

    OD: glutathione is saturated with lots of NAPQI and is depleted
    NAPQI is toxic to liver = hepatoxicity and nephropathy

  • N-acetylcysteine (Mucomyst, Parvolex): precursor of Glutathione
    Guidelines for Management of AOD (pdf)

  • Acetaminophen level
    • take assay at 4 hours post-ingestion or ASAP if more than 4 hours
    • above 200 ug/mL at 4 hours or 50 ug/mL at 12 hours = hepatotoxic
    • Rumack-Matthew normogram: in order to err on the safe side, treatment line is drawn 25% below Rumack-Matthew line
    • if below treatment line, NAC is unnecessary, or if already started, may discontinue
    • if above treatment line, NAC complete course should be given even subsequent levels are below treatment line

    • If a patient presents within 4 hours, withhold NAC until levels are out, PROVIDED that initiation of treatment is not delayed beyond 8 hours post-ingestion
    • If a patient presents more than 8 hours, start NAC REGARDLESS of amount ingested. Do not wait for assay.

  • Management: ABCDEFG
    (1) Activated Charcoal: 50 g if less than 4 hours ( >2 hours, data is limited)
    - 1g/kg, resuspended with water to achieve 25% concentration, dose is 10:1 ratio of activated charcoal to toxin
    - not absorbed: PHAILS
    • Pesticides, Potassium
    • Hydrocarbons
    • Acids, Alkalis, Alcohol
    • Iron, Insecticides
    • Lithium
    • Solvents

    (2) N-acetylcysteine:
    IV: total of 300 mg/kg in 24 hours
    • 150 mg/kg + 200 mL 5% Dextrose in 15-60 mins
    • 50 mg/kg + 500 mL 5% Dextrose in 4 hours
    • 100 mg/kg + 1L 5% Dextrose in 16 hours
      = anaphylactoid reaction: PFUN (Pruritus, Flushing, Urticaria, Nausea, etc)
      Tx: Give slower
    Oral: 140 mg/kg LD, then 17 doses of 70 mg/kg at 4-hour intervals
    - total duration: 72 hours

  • LABS
    • healthy, asymptomatic patient presenting early, only acetaminophen level
    • in symptomatic or with elevated acetaminophen, ALT and AST, then daily
    • in patients with liver injury: bilirubin, PT/INR, creatinine, BUN, electrolytes, blood glucose, lactate, phosphate, pH tests

    • For Extended Release tablets: take it at 4 hours post-ingestion as there is no protocol, but some do a second level 4-6 hours after first assay
      - if either is above treatment line, start NAC
      - if either is below, discontinue NAC if already started
  • Special considerations:
    • Children below 6yo, hepatotoxicity is rare due to different metabolism, same approach but different dose
    • Pregnant: treat as non pregnant although NAC enters placental barrier
    • >24 hours, ALT/AST should be taken; IV NAC improves survival for those on fulminant hepatic failure; Rumack-Matthew is useless
    • Alcoholics: more prone to hepatotoxicity, but same approach
    • Repeated supratherapeutic (chronic) OD: ingestion of toxic amounts over a period of longer than 8 hours
      - Rumack-Matthew is useless
      - NAC should be given if assay is >10 mg/L or with liver injury (AST/ALT)
      - NAC for 12 hours, then evaluate
      - may discontinue if clinically well, AST/ALT improving, assay <10>